ScholarIQanswers from OpenAlex

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies

PaperCitations, authors & open-access status

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies have?

ScholarIQcitation count

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies has 77 citations in the OpenAlex counts ScholarIQ stores.

When was Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies published?

ScholarIQyear

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies has 2021 year in the ScholarIQ index.

What is the open-access status of Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?

ScholarIQoa status

Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies has hybrid oa status in the ScholarIQ index.

What is the DOI of Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?

ScholarIQdoi

The DOI for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is on the source record.

What is the PMID of Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?

ScholarIQpmid

The PMID for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is on the source record.

What is the OpenAlex record for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies?

ScholarIQopenalex

The OpenAlex for Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial